[go: up one dir, main page]

SE510812C2 - (-)-(3R)-3-metyl-4-(4-(4-(4-pyridyl)piperazin-1- yl)fenoxi)smörsyra som cellulär adhesionsinhibitor - Google Patents

(-)-(3R)-3-metyl-4-(4-(4-(4-pyridyl)piperazin-1- yl)fenoxi)smörsyra som cellulär adhesionsinhibitor

Info

Publication number
SE510812C2
SE510812C2 SE9700203A SE9700203A SE510812C2 SE 510812 C2 SE510812 C2 SE 510812C2 SE 9700203 A SE9700203 A SE 9700203A SE 9700203 A SE9700203 A SE 9700203A SE 510812 C2 SE510812 C2 SE 510812C2
Authority
SE
Sweden
Prior art keywords
pharmaceutically acceptable
optically active
active compound
ester
methyl
Prior art date
Application number
SE9700203A
Other languages
English (en)
Swedish (sv)
Other versions
SE9700203L (sv
SE9700203D0 (sv
Inventor
Stuart Dennett Mills
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/457,538 external-priority patent/US5652242A/en
Priority claimed from GBGB9518188.9A external-priority patent/GB9518188D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of SE9700203L publication Critical patent/SE9700203L/xx
Publication of SE9700203D0 publication Critical patent/SE9700203D0/xx
Publication of SE510812C2 publication Critical patent/SE510812C2/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE9700203A 1995-06-01 1997-01-24 (-)-(3R)-3-metyl-4-(4-(4-(4-pyridyl)piperazin-1- yl)fenoxi)smörsyra som cellulär adhesionsinhibitor SE510812C2 (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/457,538 US5652242A (en) 1993-03-29 1995-06-01 Heterocyclic derivatives
GBGB9518188.9A GB9518188D0 (en) 1995-09-07 1995-09-07 Optically active derivative
PCT/GB1996/001260 WO1996038416A1 (fr) 1995-06-01 1996-05-28 Acide (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy}butyrique inhibiteur d'adhesion cellulaire

Publications (3)

Publication Number Publication Date
SE9700203L SE9700203L (sv) 1997-01-24
SE9700203D0 SE9700203D0 (sv) 1997-01-24
SE510812C2 true SE510812C2 (sv) 1999-06-28

Family

ID=26307696

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9700203A SE510812C2 (sv) 1995-06-01 1997-01-24 (-)-(3R)-3-metyl-4-(4-(4-(4-pyridyl)piperazin-1- yl)fenoxi)smörsyra som cellulär adhesionsinhibitor

Country Status (31)

Country Link
EP (1) EP0796247A1 (fr)
JP (1) JP2885941B2 (fr)
KR (1) KR100245957B1 (fr)
AT (1) AT406675B (fr)
AU (1) AU710105B2 (fr)
BE (1) BE1009520A5 (fr)
BR (1) BR9606409A (fr)
CA (1) CA2194397A1 (fr)
CH (1) CH691808A5 (fr)
CZ (1) CZ26997A3 (fr)
DE (1) DE19680509T1 (fr)
DK (1) DK10697A (fr)
ES (1) ES2137886B1 (fr)
FI (1) FI970393A0 (fr)
GB (1) GB2304340B (fr)
GR (1) GR1002702B (fr)
HU (1) HUP9700274A3 (fr)
IE (1) IE960405A1 (fr)
IL (1) IL118477A0 (fr)
IT (1) IT1290839B1 (fr)
LU (1) LU90008B1 (fr)
MC (1) MC2418A1 (fr)
MX (1) MX9700379A (fr)
NL (1) NL1003243C2 (fr)
NO (1) NO307460B1 (fr)
NZ (1) NZ308597A (fr)
PL (1) PL318440A1 (fr)
SE (1) SE510812C2 (fr)
SK (1) SK13097A3 (fr)
TR (1) TR199700020T1 (fr)
WO (1) WO1996038416A1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0100158A3 (fr) * 1982-07-28 1985-03-27 The Upjohn Company Hétéroalkysylalkanoles 3-pyridinyliques, leurs acides alkanoiques et leurs esters
GB8609630D0 (en) * 1986-04-19 1986-05-21 Pfizer Ltd Anti-arrhythmia agents
US5563141A (en) * 1993-03-29 1996-10-08 Zeneca Limited Heterocyclic compounds
SK120895A3 (en) * 1993-03-29 1996-06-05 Zeneca Ltd Pyridine derivatives, process for preparing the same and intermediate products in this process and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
LU90008B1 (fr) 1997-04-16
HU9700274D0 (en) 1997-04-28
JPH09512836A (ja) 1997-12-22
ATA900596A (de) 1999-12-15
WO1996038416A1 (fr) 1996-12-05
SE9700203L (sv) 1997-01-24
CA2194397A1 (fr) 1996-12-05
ES2137886B1 (es) 2000-08-16
EP0796247A1 (fr) 1997-09-24
AU710105B2 (en) 1999-09-16
SE9700203D0 (sv) 1997-01-24
ITMI961113A1 (it) 1997-12-01
GR1002702B (el) 1997-05-22
KR970704689A (ko) 1997-09-06
IE960405A1 (en) 1996-12-11
GB9627127D0 (en) 1997-02-19
DE19680509T1 (de) 1997-12-04
ITMI961113A0 (it) 1996-05-31
NO307460B1 (no) 2000-04-10
FI970393L (fi) 1997-01-30
FI970393A7 (fi) 1997-01-30
IT1290839B1 (it) 1998-12-14
AU5827296A (en) 1996-12-18
NO970437L (no) 1997-02-20
NO970437D0 (no) 1997-01-31
BE1009520A5 (fr) 1997-04-01
NL1003243C2 (nl) 1996-12-04
FI970393A0 (fi) 1997-01-30
KR100245957B1 (ko) 2000-04-01
MC2418A1 (fr) 1997-05-23
HUP9700274A3 (en) 2000-02-28
CH691808A5 (de) 2001-10-31
ES2137886A1 (es) 1999-12-16
GB2304340A (en) 1997-03-19
SK13097A3 (en) 1997-08-06
HUP9700274A2 (hu) 1999-06-28
IL118477A0 (en) 1996-09-12
CZ26997A3 (en) 1997-08-13
JP2885941B2 (ja) 1999-04-26
AT406675B (de) 2000-07-25
DK10697A (da) 1997-04-01
GB2304340B (en) 1998-07-29
MX9700379A (es) 1997-04-30
TR199700020T1 (tr) 1997-04-22
PL318440A1 (en) 1997-06-09
NZ308597A (en) 1998-11-25
BR9606409A (pt) 1997-09-30

Similar Documents

Publication Publication Date Title
CN110831945B (zh) 用于治疗疼痛的11,13-修饰的石房蛤毒素类化合物
JP2020528918A (ja) アンドロゲン受容体の標的化分解のための化合物および方法
MX2015002695A (es) Derivados biciclicos fusionados de sulfamoilo y su uso como medicamentos para el tratamiento de la hepatitis b.
EP3398598B1 (fr) Dérivé du sulfonamide, son procédé de préparation et son procédé d'utilisation
KR102068237B1 (ko) 무스카린 m1 수용체 양성 알로스테릭 조절제로서 플루오로인돌 유도체
NZ544006A (en) Substituted diketopiperazines and their pharmaceutical use as oxytocin antagonists
FR2758329A1 (fr) Derives d'imidazole-4-butane boronique, leur preparation et leur utilisation en therapeutique
US20080221063A1 (en) Heterocyclic Sulfonamide Derivatives As Inhibitors Of Factor Xa
US20050004119A1 (en) 2-(3-Sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors
SE510812C2 (sv) (-)-(3R)-3-metyl-4-(4-(4-(4-pyridyl)piperazin-1- yl)fenoxi)smörsyra som cellulär adhesionsinhibitor
WO1996020179A1 (fr) Derives de la piperazine-2,5-dione utilises comme modulateurs de la resistance multiple aux medicaments
CA3213396A1 (fr) Compositions et methodes de traitement de l'anemie associee a un trouble ribosomique
EP0120534B1 (fr) Dérivé d'acide thiolactique à activité bronchosécrétolitique
US5675011A (en) Process for producing pyrrolidine derivative and salt thereof
SK283634B6 (sk) Butadiénový, aminobutadiénový a pyrolidínový derivát a spôsoby ich prípravy
JP2003520791A (ja) 置換フェニルアミジン、これらの化合物を含む医薬組成物及びこれらの調製方法
CN1155884A (zh) 作为细胞粘连抑制剂的(-)-(3r)-3-甲基-4-(4-(4-(4-吡啶基)哌嗪-1-基)苯氧基)丁酸
JPH02311479A (ja) キノリン誘導体
FR2734818A1 (fr) Acide (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazine-1-yl- phenoxy}-butyrique, procede pour sa preparation et composition pharmaceutique le contenant
HK1000889A (en) (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy}butyric acid as cellular adhesion inhibitor
MXPA06004271A (en) Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics

Legal Events

Date Code Title Description
NUG Patent has lapsed